News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ASTRO Release: High Doses of Stereotactic Body Radiotherapy for Patients With Organ-Confined Prostate Cancer Shows High Relapse-Free Survival



10/31/2012 7:08:08 AM

BOSTON, Oct. 30, 2012 (GLOBE NEWSWIRE) -- Patients with organ-confined prostate cancer have new treatment options using high doses of focused stereotactic body radiotherapy (SBRT) instead of traditional lengthy treatment courses or surgery, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting.

Read at GlobeNewswire


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES